BD TO ANNOUNCE FISCAL 2022 FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS
BD (Becton, Dickinson and Company) will announce its fiscal 2022 fourth quarter and full year financial results on November 10, 2022, at approximately 6:30 a.m. ET. The announcement will provide summarized financial information for the quarter and full year ending on September 30, 2022.
An audio webcast will follow at 8 a.m. ET on the same day to discuss the results and company operations. Investors can access the release and the webcast on BD's investor relations website.
- None.
- None.
FRANKLIN LAKES, N.J., Oct. 13, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX) announced today that it will report its fiscal 2022 fourth quarter and full year financial results on Thursday, November 10, 2022. A news release will be issued at approximately 6:30 a.m. Eastern Time (ET) and will be available at www.bd.com/investors, along with related presentation materials. The news release and presentation materials will include summary financial information for the company's fiscal 2022 fourth quarter and full year financial results, which ended on Friday, September 30, 2022.
BD management will host an audio webcast at 8 a.m. ET on November 10, 2022 to discuss its financial results and provide an update on its operations and strategy. The audio webcast can be accessed at BD's investor relations website at www.bd.com/investors and a replay will be available shortly after the call at the same website.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics, and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Any forward-looking statements are subject to risks and uncertainties such as those described in BD's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts: | |
Media | Investors |
Troy Kirkpatrick | Francesca DeMartino |
VP, Public Relations | SVP, Investor Relations |
858.617.2361 | 201.847.5743 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-to-announce-fiscal-2022-fourth-quarter-and-full-year-financial-results-301648999.html
SOURCE BD (Becton, Dickinson and Company)
FAQ
When will BD report its fourth quarter and full year financial results for 2022?
What time is BD's audio webcast for financial results?
What date did BD's fiscal year 2022 end?
Where can I find BD's financial results announcement?
